ITP definitions: Time for an update

Affiliations

¹ Departments of Research and Haemato-oncology, Østfold Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
² Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
³ Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Waleed Ghanima et al. Br J Haematol. 2023 Jun.

. 2023 Jun;201(5):1005-1006.

doi: 10.1111/bjh.18791. Epub 2023 Apr 2.

¹ Departments of Research and Haemato-oncology, Østfold Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
² Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
³ Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

References

1. Kuter DJ. Novel therapies for immune thrombocytopenia. Br J Haematol. 2022;196(6):1311-28.
1. Boyle S, White RH, Brunson A, Wun T. Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood. 2013;121(23):4782-90.
1. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-817.
1. Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-66.
1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-93.